Abstract
When an HLA-matched sibling is not available and nontransplant approaches have been ineffective, transplantation of hematopoietic stem cells from an unrelated donor can effect a cure in some patients with chronic myelogenous leukemia. Even when successful, however, transplantation is a rigorous and prolonged process whose complications include infection and graft-versus-host disease. Improvements in hematopoietic stem-cell transplantation as well as innovative nontransplant approaches may improve the outcome in these patients.
Original language | English (US) |
---|---|
Pages (from-to) | 43-56 |
Number of pages | 14 |
Journal | Hospital practice |
Volume | 35 |
Issue number | 8 |
DOIs | |
State | Published - Aug 15 2000 |